NCT03565692 Lum-Iva-biota: Exploring the Respiratory Mycobiota and Microbiota Profile in French CF Patients Taking Lumacaftor-Ivacaftor Status UNKNOWN Phase N/A
NCT03560726 Telehealth Cognitive Behavioral Stress Management for Adults With Cystic Fibrosis Status COMPLETED Phase NA
NCT03559062 A Study to Evaluate Efficacy and Safety of TEZ/IVA in Subjects Aged 6 Through 11 Years With Cystic Fibrosis Status COMPLETED Phase PHASE3
NCT03551691 Proton Pump Inhibitors (PPI) and Fat Absorption in Cystic Fibrosis (CF) and Exocrine Pancreatic Insufficiency (EPI) Status COMPLETED Phase PHASE2
NCT03540524 A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis. Status COMPLETED Phase PHASE1
NCT03537651 A Study to Evaluate the Safety and Efficacy of Long-term Treatment With TEZ/IVA in CF Participants With an F508del CFTR Mutation Status COMPLETED Phase PHASE3
NCT03534986 Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements Status COMPLETED Phase NA
NCT03527095 A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03525574 A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy Status COMPLETED Phase PHASE3
NCT03525548 A Study of VX-445 Combination Therapy in CF Subjects Homozygous for F508del (F/F) Status COMPLETED Phase PHASE3
NCT03525444 A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF) Status COMPLETED Phase PHASE3
NCT03524859 Evaluation of Sit-to-stand Test in Patients With Cystic Fibrosis and Matched Controls. Status COMPLETED Phase N/A
NCT03518697 Effects of an Individualized Exercise Program on Health-related and Skill/Performance-related fitness in CF. Status COMPLETED Phase NA
NCT03516331 A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03502070 Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules Status COMPLETED Phase PHASE4
NCT03500263 Safety, Tolerability, and Pharmacokinetics of PTI-808, PTI-801, and PTI-428 Combination Therapy in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT03497117 19F MRI of Ventilation in Subjects With Cystic Fibrosis Undergoing Treatment for Pulmonary Exacerbation Status TERMINATED Phase EARLY_PHASE1
NCT03494894 Bacteriological Link Between Upper and Lower Airways in Cystic Fibrosis and Primary Ciliary Dyskinesia Status COMPLETED Phase N/A